Proteomics International receives $2.2m in R&D tax incentive
Filed with ASX · · 2 pages · English
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- PromarkerEndo test for endometriosis receives $0.5m grant
- Collaboration expanded to advance Endometriosis blood test
- Proteomics granted certification for Diagnostics Laboratory
- Board and Management Transition
- PromarkerEso precisely detects early stage esophageal cancer
Later from Proteomics International Laboratories
- OxiDx test correlates with superior racehorse performance
- US Medicare sets reimbursement price for PromarkerD DKD test
- Response to ASX Price Query
- PromarkerD predicts risk of DKD in Aboriginal Australians
- US patent secured for PromarkerEso diagnostic test for EAC
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories